Search Results
126 items found for "Libin Ye"
- Fusion protein strategies for cryo-EM study of G protein-coupled receptors
alone without signaling protein, the critical determinants that make this approach successful are not yet
- The NPXXY Motif Regulates β-Arrestin Recruitment by the CB1 Cannabinoid Receptor
have focused on the G-protein signaling state, the mechanism for β-arrestin signaling by CB1 is not yet
- Join Dr. GPCR Summit 2022 in 3 simple steps!
GPCR event of the year is the 3rd edition of the Summit.
- Platelets in the NETworks interweaving inflammation and thrombosis
Research over the past years has provided a substantial body of evidence demonstrating that platelets
- Isoforms of GPR35 have distinct extracellular N-termini that allosterically modify...
Our results reveal that the extended N-terminus of the long isoform limits G protein activation yet elevates
- Cell Surface Calcium-Sensing Receptor Heterodimers: Mutant Gene Dosage Affects Ca 2+ Sensing but...
homozygous inactivating mutations, which have implications for disorders of calcium metabolism are not yet
- Cholesterol occupies the lipid translocation pathway to block phospholipid scrambling by a GPCR
Yet phospholipid scrambling is not detectable in the resting plasma membrane of mammalian cells that
- A central alarm system that gates multi-sensory innate threat cues to the amygdala
Yet little is known about whether and how multi-sensory innate threat cues are integrated and conveyed
- Phosphorylation of RGS regulates MAP kinase localization and promotes completion of cytokinesis
September 2022 "Yeast use the G-protein–coupled receptor signaling pathway to detect and track the mating
- Identification of hub genes in the subacute spinal cord injury in rats
It has been discovered in recent years that inflammatory responses are particularly important in subacute
- CD28 and chemokine receptors: Signalling amplifiers at the immunological synapse
During years, several studies have depicted the pivotal role of the cytoskeleton and lipid microdomains
- PAR-Induced Harnessing of EZH2 to β-Catenin: Implications for Colorectal Cancer
G-protein-coupled receptors (GPCRs) are involved in a wide array of physiological and disease functions, yet
- The Impact of CB1 Receptor on Nuclear Receptors in Skeletal Muscle Cells
It is as yet unknown whether these CB1 receptors contribute to pathways underlying skeletal muscle biological
- Addex Raises $10 Million In Equity Financing
$6.50 per ADS, will become exercisable in 60 days after their date of issuance and will expire six years
- Carola Weiss joins InterAx Biotech AG as VP Business Development
Carola Weiss is a Senior Executive with more than 20 years of international experience in the biopharmaceutical
- Oxford Professor Of Chemistry And Founder Of Therapeutic Company Wins Two International Awards
This is a highly prestigious international award – exemplified by the fact that other winners this year
- Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences
US$100 million, with the amount to be recognized as revenue in the fourth quarter of the financial year
- Verily links up with Sosei Heptares for GPCR drug discovery
January 2022 "G-protein-coupled receptors’ star has been on the rise in biotech in recent years as researchers
- Novo Nordisk moves to strengthen obesity efforts
January 2022 "After securing FDA approval for Wegovy last year, Novo Nordisk is strengthening its position Although specific details of the collaboration are yet to be released, EraCal has confirmed that the
- Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with ...
the fruitful research space has led to more than 700 approved drugs over previous decades—but the two-year-old The company's co-founder, GPCR pioneer and Nobel laureate Robert Lefkowitz, M.D., has 50 years of experience
- Targeted Therapies to Reduce Side Effects in Modern Drug Development
cell and the astonishing diversity of diseases are just two reasons why researchers typically require years
- Anatomy of a partnership: Cancer Research UK teams up with Sosei Heptares
dedicated to funding lifesaving oncology research, spent £388 million on cancer research last fiscal year
- Pharmacophore-guided Virtual Screening to Identify New β 3 -adrenergic Receptor Agonists
Ligand-based pharmacophore modeling was performed since no 3D structure of human β3 -AR is yet available
- Addex raises $4.2 million in equity financing
$1.90 per ADS, will become exercisable in 60 days after their date of issuance and will expire five years
- Neurocrine Biosciences Presents Data on Treatment of Adolescent Patients with Classic Congenital ...
with Classic CAH - Two Phase 3 Global Registrational Studies Currently Underway in Pediatric (2–17 years of age) and Adult (18 years of age and older) Patients with Classic CAH SAN DIEGO, June 13, 2022 -
- Inversago Pharma appoints Glenn S. Vraniak as Chief Financial Officer
Vraniak’s career spans more than 20 years of financial and commercial experience in the life sciences successful IPO on Nasdaq in February 2021, and successfully raised follow-on capital later that same year
- Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B ...
Topline results from 40 subjects are expected in the second half of the calendar year."
- Applications of Cryo-EM in small molecule and biologics drug design
In recent years, pharmaceutical companies have begun to utilize cryo-EM for structure-based drug design